vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
19.67
-0.03 (-0.15%)
Apr 21, 2025, 4:00 PM EDT - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $62.74 million as of April 21, 2025. Its market cap has decreased by -18.31% in one year.
Market Cap
62.74M
Enterprise Value
26.08M
1-Year Change
-18.31%
Ranking
Category
Stock Price
$19.67
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $62.74M, a decrease of -82.44%. That is a compound annual growth rate of -16.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 62.70M | 42.50% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.93B |
| UnitedHealth Group | 395.61B |
| Johnson & Johnson | 376.90B |
| AbbVie | 299.84B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 223.73B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |